These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37336312)

  • 1. Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis.
    Titus A; Cheema HA; Shafiee A; Seighali N; Shahid A; Bhanushali KB; Kumar A; Khan SU; Khadke S; Thavendiranathan P; Hundley WG; Scherrer-Crosbie M; Nohria A; Neilan TG; Dani SS; Nasir K; Ganatra S
    Curr Probl Cardiol; 2023 Oct; 48(10):101885. PubMed ID: 37336312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    D'Amario D; Laborante R; Bianchini E; Galli M; Ciliberti G; Mennuni M; Patti G
    Int J Cardiol; 2023 Nov; 391():131219. PubMed ID: 37527752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials.
    Felix N; Nogueira PC; Silva IM; Costa TA; Campello CA; Stecca C; Lopes RD
    Eur J Intern Med; 2024 Aug; 126():43-48. PubMed ID: 38643042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
    Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
    Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
    Thavendiranathan P; Houbois C; Marwick TH; Kei T; Saha S; Runeckles K; Huang F; Shalmon T; Thorpe KE; Pezo RC; Prica A; Maze D; Abdel-Qadir H; Connelly KA; Chan J; Billia F; Power C; Hanneman K; Wintersperger BJ; Brezden-Masley C; Amir E
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):515-525. PubMed ID: 37120736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis.
    Alizadehasl A; Ghadimi N; Kaveh S; Maleki M; Ghavamzadeh A; Noohi F; Hosseinifard H
    Int J Clin Pharm; 2021 Feb; 43(1):25-34. PubMed ID: 32910372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
    J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity: A Three Dimentional Echocardiography Study.
    Mohamed AL; El-Abd AA; Mohamed HG; Noufal AM; Hennawy BS
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102130. PubMed ID: 37858847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis.
    Musella F; Librera M; Sibilio G; Boccalatte M; Tagliamonte G; Cavaglià E; Ferrara I; Puglia M; Dell'Aversana S; Ducci CB; Dellegrottaglie S; Savarese G; Scatteia A
    Curr Probl Cardiol; 2024 Jul; 49(7):102609. PubMed ID: 38697332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis.
    Caspani F; Tralongo AC; Campiotti L; Asteggiano R; Guasti L; Squizzato A
    Intern Emerg Med; 2021 Mar; 16(2):477-486. PubMed ID: 33011930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis.
    Chiang CH; Chang YC; Haw Y; Tan JY; Chiang CH; Hsia YP; Chiang CH
    Oncology; 2024; 102(6):510-514. PubMed ID: 38104536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function.
    Chotenimitkhun R; D'Agostino R; Lawrence JA; Hamilton CA; Jordan JH; Vasu S; Lash TL; Yeboah J; Herrington DM; Hundley WG
    Can J Cardiol; 2015 Mar; 31(3):302-7. PubMed ID: 25662284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins to prevent anthracycline-related myocardial toxicity: The jury is still out.
    Mandalà M; Bartolini C; Becattini C
    Eur J Intern Med; 2024 Aug; 126():41-42. PubMed ID: 38852023
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardioprotective Effects and Duration of Beta Blocker Therapy in Anthracycline-Treated Patients: A Systematic Review and Meta-analysis.
    Xu L; Long Y; Tang X; Zhang N
    Cardiovasc Toxicol; 2020 Feb; 20(1):11-19. PubMed ID: 31832905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials.
    Attar A; Behnagh AK; Hosseini M; Amanollahi F; Shafiekhani P; Kabir A
    Cardiovasc Ther; 2022; 2022():8367444. PubMed ID: 36687509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials.
    Ma Y; Bai F; Qin F; Li J; Liu N; Li D; Li T; Xie H; Liu D; Zhou S; Liu Q
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):18. PubMed ID: 31023386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
    Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
    J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Agarwal S; Guha A; Krishan S; Naqash AR; Addison D; Yang EH; Barac A; Asad ZUA
    Am J Cardiol; 2023 Nov; 206():63-66. PubMed ID: 37683579
    [No Abstract]   [Full Text] [Related]  

  • 19. ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis.
    Gao Y; Wang R; Jiang J; Hu Y; Li H; Wang Y
    Heart Fail Rev; 2023 Nov; 28(6):1405-1415. PubMed ID: 37414918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of beta-blockers in chemotherapy-induced cardiotoxicity-a systematic review and meta-analysis of carvedilol.
    Huang S; Zhao Q; Yang ZG; Diao KY; He Y; Shi K; Shen MT; Fu H; Guo YK
    Heart Fail Rev; 2019 May; 24(3):325-333. PubMed ID: 30523513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.